ξτχθ
|
ων δϊψετδ αΰπβμιϊ: Mepact.
ξητωιν ϊψετδ ΰηψϊ? λπρε μΰιπγχρ δϊψετεϊ »
|
|
 αρμ δαψιΰεϊ
φεψϊ ξϊο
I.V
ξιπεο
Powder For Concentrate For Dispersion For Infusion
ωιξεω αϊψετδ
Mepact is indicated in children, adolescents and young adults for the treatment of high grade resectable non metastatic osteosarcoma after macroscopically complete surgical resection. It is used in combination with post operative multi-agent chemotherapy. Safety and efficacy have been assessed in studies of patients 2 to 30 years of age at initial diagnosis.
ξρτψ ψιωεν
147 07 33425 00
ιφψο
Bsp Pharnaceuticals S.r. L
ϊεχσ ψιωιεο μϊψετδ
01/2012 - 12/2016
ηεξψ τςιμ
|
ψιλεζ / λξεϊ αιηιγϊ ξιπεο
|
Mifamurtide |
4 MG/VIAL |
ΰψιζδ
|
λξεϊ αΰψιζδ
|
ηιι ξγσ
|
ϊψετϊ ξψων
|
Vial glass type i |
1 x 50 ML |
ηεγωιν 30 |
λο |
|
|
|